New drug trial offers hope for Tough-to-Treat cancers
NCT ID NCT06927687
Summary
This study is testing whether the experimental drug ZG005 can help control advanced solid tumors in people who haven't responded to standard treatments. The trial will enroll 100 adults with various advanced cancers to see how well the drug works and how safe it is. Researchers will measure tumor shrinkage and monitor side effects to determine if ZG005 could become a new treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, China
Contact
Conditions
Explore the condition pages connected to this study.